HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review

Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics:

· Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib (0:00)

· Case: A woman in her early 60s with multiregimen-recurrent HER2-mutant metastatic NSCLC experiences a response to zongertinib (8:07)

· Case: A man in his mid 80s experiences metastatic recurrence after resection of PD-L1-positive, HER2-mutant metastatic NSCLC (17:50)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.